[go: up one dir, main page]

UY29289A1 - SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME - Google Patents

SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME

Info

Publication number
UY29289A1
UY29289A1 UY29289A UY29289A UY29289A1 UY 29289 A1 UY29289 A1 UY 29289A1 UY 29289 A UY29289 A UY 29289A UY 29289 A UY29289 A UY 29289A UY 29289 A1 UY29289 A1 UY 29289A1
Authority
UY
Uruguay
Prior art keywords
dosage form
proton pump
pump inhibitor
same
solid dosage
Prior art date
Application number
UY29289A
Other languages
Spanish (es)
Inventor
Persson Eva
Trofast Eva
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to UY29289A priority Critical patent/UY29289A1/en
Publication of UY29289A1 publication Critical patent/UY29289A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Una forma de dosificación farmacéutica oral sólida que gelifica rápidamente, así como suspensiones acuosas preparadas a partir de la misma, que comprende un inhibidor de la bomba de protones sensible al ácido como ingrediente activo distribuido en una multitud de gránulos recubiertos entéricamente y un granulado modificador de la suspensión. Asimismo, la invención se refiere a un procedimiento mejorado para su fabricación y el uso de dicha formulación en el tratamiento médico, inclusive la prevención de trastornos gastrointestinales en seres humanos.A solid oral pharmaceutical dosage form that gels rapidly, as well as aqueous suspensions prepared therefrom, comprising an acid-sensitive proton pump inhibitor as an active ingredient distributed in a multitude of enteric coated granules and a modifying granulate. the suspension. Likewise, the invention relates to an improved process for its manufacture and the use of said formulation in medical treatment, including the prevention of gastrointestinal disorders in humans.

UY29289A 2005-12-21 2005-12-21 SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME UY29289A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY29289A UY29289A1 (en) 2005-12-21 2005-12-21 SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY29289A UY29289A1 (en) 2005-12-21 2005-12-21 SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME

Publications (1)

Publication Number Publication Date
UY29289A1 true UY29289A1 (en) 2006-07-31

Family

ID=38813126

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29289A UY29289A1 (en) 2005-12-21 2005-12-21 SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME

Country Status (1)

Country Link
UY (1) UY29289A1 (en)

Similar Documents

Publication Publication Date Title
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
NO20064041L (en) Substituted pyrazoline compositions, their preparation and use as drugs
CY1118661T1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCEDURE FOR THEIR PREPARATION, METHODS FOR TREATMENT AND USE OF THESE
MA32200B1 (en) New formulations, tablets consisting of these formulas, their use and method of preparation
UA94942C2 (en) Dpp iv inhibitor formulations
ECSP088560A (en) FORMULATION OF SUSTAINED RELEASE THAT INCLUDES OCTREOTIDE AND TWO OR MORE POLYMACTIDE-CO-GLYCOLIDE POLYMERS
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
UA103915C2 (en) A SOLID MEDICINAL FORM THAT CONTAINS LINAGLIPTIN AND SGLT2 INHIBITOR, AND ITS APPLICATION
CL2011000170A1 (en) Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation.
AR058679A1 (en) PHARMACEUTICAL PREPARATION CONTAINING MELOXICAM
EA201171286A1 (en) NEW TECHNOLOGY OF INDOMETACINE MANUFACTURING
WO2010111640A3 (en) Anti-influenza formulations and methods
NO20064186L (en) Substituted pyrazoline compositions to reduce blood triglycerides
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
NZ605469A (en) Nalbuphine-based formulations and uses thereof
CY1114190T1 (en) NEW FORM OF RASKADOTRIL ADMINISTRATION
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
NO20064078L (en) Substituted azetidine compositions, their preparation and use as drugs
CR20110704A (en) COMPOSITIONS OF FIXED DOSAGE SOLID PHARMACEUTICALS THAT INCLUDE IRBESARTAN AND AMYLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION
DK1746980T3 (en) Pharmaceutical dosage form comprising pellets as well as their manufacturing process
TR200900879A2 (en) Pharmaceutical compositions in which the active ingredients are combined in a single dosage form
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
AR070392A1 (en) COMPOSITIONS OF ORAL DISINTEGRATION RANITIDINE TABLETS AND ITS ELEBORATION METHODS
MX2008011020A (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor.
UY29289A1 (en) SOLID DOSAGE FORM INCLUDED BY A PROTON PUMP INHIBITOR AND A SUSPENSION OBTAINED FROM THE SAME

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160606